Cargando…
Pathology of Hereditary Breast and Ovarian Cancer
Hereditary breast and ovarian cancer (HBOC) syndrome is most commonly characterized by deleterious germline mutations in BRCA1 and BRCA2. HBOC patients are prone to the development of malignant neoplasms in multiple organs including the breast, ovary, and fallopian tube. From a pathological perspect...
Autores principales: | Hodgson, Anjelica, Turashvili, Gulisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550871/ https://www.ncbi.nlm.nih.gov/pubmed/33117676 http://dx.doi.org/10.3389/fonc.2020.531790 |
Ejemplares similares
-
Editorial: Hereditary Breast and Ovarian Cancer: Current Concepts of Prevention and Treatment
por: Grabenstetter, Anne, et al.
Publicado: (2020) -
Tumor Heterogeneity in Breast Cancer
por: Turashvili, Gulisa, et al.
Publicado: (2017) -
What’s new in gynecologic pathology 2021: ovary and fallopian tube
por: Turashvili, Gulisa, et al.
Publicado: (2021) -
Are Columnar Cell Lesions the Earliest Non-Obligate Precursor in the Low-Grade Breast Neoplasia Pathway?
por: Strickland, Sarah, et al.
Publicado: (2022) -
ADNP (Activity Dependent Neuroprotector Homeobox): A novel oncogene driving poor prognosis in high-grade serous carcinoma
por: Turashvili, Gulisa
Publicado: (2020)